Forgot your password? 
New user? | Show: 1 - 10 of 12 results |
Clinical Outsourcing Spend Down 20% Since 2006
|
[posted: October 21, 2008] Drugmakers are spending less on clinical development outsourcing, according to a new report by industry analysts Cutting Edge Information. The "Streamlining Clinical Trials" study suggests that pharmaceutical firms have cut their spending on outsourced trials ... details |
China No1 for Pharma Outsourcing, Says PwC
|
[posted: September 23, 2008] China is the ideal destination for outsourcing, according to a report by PriceWaterHouseCoopers (PwC) that has calculated rankings based on a range of parameters. The PwC report, "The changing dynamics of pharma outsourcing in Asia ... details |
Foreign Firms and Their Place in the Chinese Anti-tumor Drug Market
|
[posted: September 08, 2008] Multinational firms are paying more and more attention to the rapidly growing Chinese anti-tumor drug market. Medicine experts in China's anti-tumor drug industry have received high praise at the recently held 44th annual meeting of the American Society of Clinical Oncology ... details |
Sourcing APIs in Emerging Nations
|
[posted: September 05, 2008] Two years after filing a drug application, the FDA gives you the green light for your new medicine and you formally launch the product. But your work is far from done. In a few years, you can look forward to expiring patents, and if you don't have a new blockbuster drug ... details |
Pharma Outsourcing on Upward Trajectory
|
[posted: August 15, 2008] It's an old story - pharma companies are outsourcing to CROs to cut costs. Kalorama Information has tracked the growth of CRO drug discovery since the beginning of the decade. Cost savings remain a key instigator of outsourcing decisions ... details |
Biotechs Generate 30% Annual CRO Revenue
|
[posted: July 28, 2008] The 15 years, $800m (€509m) investment and one in 5,000 chance of successfully developing a new drug is likely to see more pharmaceutical firms partner with CROs in a bid to offset risk, according to a report by Turner Investment Partners (TIP) ... details |
Globalisation of Advanced R&D Services 'On the Rise'
|
[posted: July 17, 2008] Pharmaceutical companies in the developed world have already shifted substantial manufacturing and clinical trial work to emerging economies such as China and India. but a new study suggest they are increasingly counting on these countries ... details |
Contract Manufacturing Market Changing Shape
|
[posted: July 08, 2008] The contract manufacturing sector is likely to enjoy "continued and accelerating growth" in the coming years as big pharma companies continue to increase the level of outsourcing, with firms now viewing outsourcing as the default approach for making new products ... details |
Flexibility Is the Name of the Game for CROs
|
[posted: June 15, 2008] As the recent "2008 Biopharma Outsourcing" conference sponsored by iiBIG underscored, the term contract research organization (CRO) can take on a wide variety of meanings depending on the specific company it's applied to ... details |
CRO Central Lab Expansion - Market Demand Broadens Bundled Services
|
[posted: June 15, 2008] The need to accelerate drug development has led to the rise of global clinical trials in search of large patient populations. Along with increasing trial complexity, which requires more esoteric testing to be done closer to the patient ... details |
